News & Media

Novel stem cell therapy for cancer-stricken pets

N2CR member, A/Prof Too Heng-Phon, Dr Sarah Ho and team have developed a way to use stem cells to treat cancer in cats and dogs, a method originally developed for humans. The stem cells are first modified and then injected into the animal, while off-the-shelf anti-fungal drugs are taken orally.

These modified stem cells are able to specifically target and kill the cancer cells before dying off themselves. The use of this treatment has allowed animals with terminal cancer to live longer than expected, or have a better quality of life.

Read more about how A/Prof Too is helping our furry friends.
https://www.straitstimes.com/singapore/novel-cell-based-gene-therapy-developed-in-singapore-improves-lives-of-cancer-stricken-pets

 

Click below to read how A/Prof Too, Dr Ho Yoon Khei and team worked with a group of veterinarians to help dogs suffering from cancer.

Novel cancer therapy extends lives of terminally ill dogs

Share this story:
Facebook
Twitter
LinkedIn

Related News & Media

News

N2CR Enters a New Chapter

N2CR is moving into an exciting new phase. Since its establishment in 2020, N2CR has flourished under the leadership of …

Read More →
News

N2CR Retreat 2025

N2CR had its 3rd annual retreat at Grand Copthorne Waterfront Hotel on 25 July 2025. From inspiring discussions and exchanges …

Read More →
Achievements

New CAR T-Cell Therapy Offers Hope for Relapsed or Refractory T-cell Leukaemia

Relapsed/refractory T-cell acute lymphoblastic leukemia (T-ALL) is challenging to treat. Outcome for such patients is dismal. A recent experimental treatment …

Read More →